RxDoctor Payments Data

Michael Porayko

Gastroenterology · Nashville, TNNPI 1033206149

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $11,974 of the $12,147 with a category attached, or 98.6%. Mallinckrodt Hospital Products Inc. accounts for 77.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2021 at $6,248 and has fallen 93.4% since, to $413 in 2024.

$12,147in general payments, 2019–2025

Across 10 payments — averaging $1214.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mallinckrodt Hospital Products Inc.$9K
  • Novo Nordisk$1K
  • Gilead$550
  • Vertex$413
  • Insmed, Inc.$413
  • Mallinckrodt Enterprises LLC$73
$857,862in research payments, 2019–2025

Across 220 payments — averaging $3899.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Intercept Pharmaceuticals, Inc.$462K
  • Mallinckrodt Enterprises LLC$130K
  • AbbVie$116K
  • E.r. Squibb & Sons, L.L.C.$65K
  • Pfizer$56K
  • Gilead$18K
  • plus $11K from 3 others

What the payments were for

  • Consulting fees$11,97499%
  • Food & beverage$1731%

General payments by program year

19
20
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$12,147 in reported general payments places this provider in the 85th percentile of 336 gastroenterology providers in Tennessee.

See all gastroenterology providers in Tennessee →

Other gastroenterology in Nashville

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →